Epidemiology and Outcome in Neonatal and Pediatric Herpes Simplex Encephalitis: A 13-Year Experience in a Singapore Tertiary Children's Hospital

Abstract

Herpes simplex encephalitis (HSE) remains one of the most devastating infections of the central nervous system in children despite available antiviral therapy. Our aim was to determine the clinical epidemiology and long-term neuro-developmental outcome of neonates and children admitted to our hospital with proven HSE. Patients with HSE during November 1998 to December 2011 were identified from discharge and laboratory records and data collection was done by retrospective review of their case notes. HSE was proven by culture or polymerase chain reaction (PCR) or by a positive Herpes simplex virus (HSV)–specific intrathecal antibody. We identified 13 patients during the study period: nine neonates and four older children, all of whom were treated with intravenous acyclovir. In the neonatal cohort, three (33%) presented with seizures and only four (44%) had vesicles. The initial cerebrospinal fluid (CSF) HSV PCR was positive in seven (78%) and HSV type 2 was the most common. Repeat CSF study showed HSV positivity of 100%. Two (22%) neonates died and three (43%) had long-term neurodevelopmental sequelae. Developmental delay, focal neurological deficit, and cognitive deficit were among the most frequent neurological sequelae noted. In the pediatric cohort, three children (75%) had positive CSF HSV PCR and seizures. One (25%) died and two of the three survivors (67%) had neurodevelopmental sequelae. Early CSF studies may be negative in HSE, so a repeat CSF analysis should be considered, particularly in neonates. Early administration of acyclovir could prevent adverse outcomes in HSE.

Keywords

child - encephalitis - herpes simplex - newborn

• References

• 1 Whitley RJ, Kimberlin DW. Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis 2005; 16 (1) 17-23
• 2 Burrows J, Nitsche A, Bayly B, Walker E, Higgins G, Kok T. Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture. BMC Microbiol 2002; 2: 12
• 3 Adelson ME, Feola M, Trama J, Tilton RC, Mordechai E. Simultaneous detection of herpes simplex virus types 1 and 2 by real-time PCR and Pyrosequencing. J Clin Virol 2005; 33 (1) 25-34
• 4 Koren A, Tasher D, Stein M, Yossepowitch O, Somekh E. Neonatal herpes simplex virus infections in Israel. Pediatr Infect Dis J 2013; 32 (2) 120-123
• 5 Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009; 361 (14) 1376-1385
• 6 Kimberlin DW, Lin CY, Jacobs RF , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108 (2) 230-238
• 7 Theng TS, Chan RK. Genital herpes in a sexually-transmitted infection clinic in Singapore: a 1-year retrospective study. Ann Acad Med Singapore 2004; 33 (2) 200-203
• 8 Kropp RY, Wong T, Cormier L , et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006; 117 (6) 1955-1962
• 9 Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988; 1 (8575-6) 1-4
• 10 Kimberlin D. Herpes simplex virus, meningitis and encephalitis in neonates. Herpes 2004; 11 (Suppl. 02) 65A-76A
• 11 Kimberlin DW, Lin CY, Jacobs RF , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108 (2) 223-229
• 12 Whitley R, Arvin A, Prober C , et al; The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991; 324 (7) 450-454
• 13 Kimberlin DW, Lakeman FD, Arvin AM , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J Infect Dis 1996; 174 (6) 1162-1167
• 14 Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999; 81 (1) F24-F29
• 15 Lakeman FD, Whitley RJ ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis 1995; 171 (4) 857-863
• 16 Cantey JB, Mejías A, Wallihan R , et al. Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection. J Pediatr 2012; 161 (2) 357-361
• 17 Parker LA, Montrowl SJ. Neonatal Herpes Infection: A Review. Newborn Infant Nurs Rev 2004; 4 (1) 62-69
• 18 Engman ML, Adolfsson I, Lewensohn-Fuchs I, Forsgren M, Mosskin M, Malm G. Neuropsychologic outcomes in children with neonatal herpes encephalitis. Pediatr Neurol 2008; 38 (6) 398-405
• 19 Tebas P, Nease RF, Storch GA. Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model. Am J Med 1998; 105 (4) 287-295
• 20 De Tiège X, Rozenberg F, Héron B. The spectrum of herpes simplex encephalitis in children. Eur J Paediatr Neurol 2008; 12 (2) 72-81
• 21 De Tiège X, Héron B, Lebon P, Ponsot G, Rozenberg F. Limits of early diagnosis of herpes simplex encephalitis in children: a retrospective study of 38 cases. Clin Infect Dis 2003; 36 (10) 1335-1339
• 22 Elbers JM, Bitnun A, Richardson SE , et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease?. Pediatrics 2007; 119 (2) e399-e407
• 23 Tang YW, Hibbs JR, Tau KR , et al. Effective use of polymerase chain reaction for diagnosis of central nervous system infections. Clin Infect Dis 1999; 29 (4) 803-806
• 24 Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis 2002; 34 (8) 1154-1157
• 25 Kennedy PG, Chaudhuri A. Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 2002; 73 (3) 237-238
• 26 Ito Y, Ando Y, Kimura H, Kuzushima K, Morishima T. Polymerase chain reaction-proved herpes simplex encephalitis in children. Pediatr Infect Dis J 1998; 17 (1) 29-32
• 27 Lahat E, Barr J, Barkai G, Paret G, Brand N, Barzilai A. Long term neurological outcome of herpes encephalitis. Arch Dis Child 1999; 80 (1) 69-71
• 28 García-Ribes A, Martínez-González MJ, Prats-Viñas JM. Suspected herpes encephalitis and opercular syndrome in childhood. Pediatr Neurol 2007; 36 (3) 202-206
• 29 van der Poel JC, Haenggeli CA, Overweg-Plandsoen WC. Operculum syndrome: unusual feature of herpes simplex encephalitis. Pediatr Neurol 1995; 12 (3) 246-249
• 30 De Tiège X, Rozenberg F, Des Portes V , et al. Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology 2003; 61 (2) 241-243
• 31 Kimura H, Aso K, Kuzushima K, Hanada N, Shibata M, Morishima T. Relapse of herpes simplex encephalitis in children. Pediatrics 1992; 89 (5 Pt 1) 891-894